Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective
Authors
Keywords
-
Journal
Future Virology
Volume 8, Issue 9, Pages 871-890
Publisher
Future Medicine Ltd
Online
2013-08-27
DOI
10.2217/fvl.13.67
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Workflow Example of PBPK Modeling to Support Pediatric Research and Development: Case Study with Lorazepam
- (2013) A. R. Maharaj et al. AAPS Journal
- Clinical Pharmacokinetics of Drugs in Patients with Heart Failure
- (2013) Ryuichi Ogawa et al. CLINICAL PHARMACOKINETICS
- Prediction of drug-drug Interactions Between Various Antidepressants and Efavirenz or Boosted Protease Inhibitors Using a Physiologically Based Pharmacokinetic Modelling Approach
- (2013) Marco Siccardi et al. CLINICAL PHARMACOKINETICS
- Drug interactions between antiretrovirals and hormonal contraceptives
- (2013) Alice Tseng et al. Expert Opinion on Drug Metabolism & Toxicology
- Clinical pharmacokinetics of antiretroviral drugs in older persons
- (2013) John C Schoen et al. Expert Opinion on Drug Metabolism & Toxicology
- Predicting intestinal absorption of raltegravir using a population-based ADME simulation
- (2013) Darren M. Moss et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Overcoming pharmacologic sanctuaries
- (2013) Theodore J. Cory et al. Current Opinion in HIV and AIDS
- Physiologically Based Pharmacokinetic Modeling to Investigate Regional Brain Distribution Kinetics in Rats
- (2012) Joost Westerhout et al. AAPS Journal
- Simulation of the pharmacokinetics of bisoprolol in healthy adults and patients with impaired renal function using whole-body physiologically based pharmacokinetic modeling
- (2012) Guo-fu Li et al. ACTA PHARMACOLOGICA SINICA
- Prevalence of HIV and chronic comorbidities among older adults
- (2012) Joel Negin et al. AIDS
- The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa
- (2012) Jan A.C. Hontelez et al. AIDS
- Antiretroviral therapy adherence and drug–drug interactions in the aging HIV population
- (2012) Jean B. Nachega et al. AIDS
- Hepatorenal Syndrome: A Severe, but Treatable, Cause of Kidney Failure in Cirrhosis
- (2012) Cláudia Fagundes et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Divalent Metals and pH Alter Raltegravir DispositionIn Vitro
- (2012) Darren M. Moss et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Maternal antiretroviral prophylaxis and breastfeeding
- (2012) Catia Marzolini et al. ANTIVIRAL THERAPY
- Efavirenz in an obese HIV-infected patient – a report and an in vitro–in vivo extrapolation model indicate risk of underdosing
- (2012) Mirjam de Roche et al. ANTIVIRAL THERAPY
- Physiologically based pharmacokinetic (PBPK) modelling tools: how to fit with our needs?
- (2012) François Bouzom et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- Utility of a physiologically-based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug-drug-disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice
- (2012) Joseph A. Grillo et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4
- (2012) Lu Gaohua et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices
- (2012) Andrea Calcagno et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic Interactions Between the Hepatitis C Virus Protease Inhibitor Boceprevir and Ritonavir-Boosted HIV-1 Protease Inhibitors Atazanavir, Darunavir, and Lopinavir
- (2012) Ellen G. J. Hulskotte et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic Optimization of Antiretroviral Therapy in Pregnancy
- (2012) Kajal Buckoreelall et al. CLINICAL PHARMACOKINETICS
- Anatomical, Physiological and Metabolic Changes with Gestational Age during Normal Pregnancy
- (2012) Khaled Abduljalil et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro–In Vivo Extrapolation Model
- (2012) M Siccardi et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Best Practice in the Use of Physiologically Based Pharmacokinetic Modeling and Simulation to Address Clinical Pharmacology Regulatory Questions
- (2012) P Zhao et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- An improved model to predict physiologically based model parameters and their inter-individual variability from anthropometry
- (2012) Sieto Bosgra et al. CRITICAL REVIEWS IN TOXICOLOGY
- Etravirine
- (2012) Jamie D. Croxtall DRUGS
- HIV and Aging
- (2012) Kevin P. High et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Lopinavir/ritonavir significantly influences pharmacokinetic exposure of artemether/lumefantrine in HIV-infected Ugandan adults
- (2012) P. Byakika-Kibwika et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults
- (2012) P. Byakika-Kibwika et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation
- (2012) Ping Zhao et al. JOURNAL OF CLINICAL PHARMACOLOGY
- A mechanistic pharmacokinetic model to assess modified oral drug bioavailability post bariatric surgery in morbidly obese patients: interplay between CYP3A gut wall metabolism, permeability and dissolution
- (2012) Adam S. Darwich et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- P-Glycoprotein Function at the Blood–Brain Barrier: Effects of Age and Gender
- (2012) Daniëlle M. E. van Assema et al. MOLECULAR IMAGING AND BIOLOGY
- Lopinavir Dosing in HIV-infected Children in the United Kingdom and Ireland
- (2012) Katherine Donegan et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Pharmacogenetics-based population pharmacokinetic analysis of etravirine in HIV-1 infected individuals
- (2012) Rubin Lubomirov et al. Pharmacogenetics and Genomics
- Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding
- (2012) Adeniyi Olagunju et al. PHARMACOGENOMICS
- The Burden of Liver Disease in Human Immunodeficiency Virus-Infected Patients
- (2012) Massimo Puoti et al. SEMINARS IN LIVER DISEASE
- Correlates of Efavirenz Exposure in Chilean Patients Affected With Human Immunodeficiency Virus Reveals a Novel Association With a Polymorphism in the Constitutive Androstane Receptor
- (2012) Claudia P. Cortes et al. THERAPEUTIC DRUG MONITORING
- Physiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
- (2011) Malcolm Rowland et al. Annual Review of Pharmacology and Toxicology
- The Expression and Function of Organic Anion Transporting Polypeptides in Normal Tissues and in Cancer
- (2011) Amanda Obaidat et al. Annual Review of Pharmacology and Toxicology
- Interplay of Metabolism and Transport in Determining Oral Drug Absorption and Gut Wall Metabolism: A Simulation Assessment Using the “Advanced Dissolution, Absorption, Metabolism (ADAM)” Model
- (2011) A. S. Darwich et al. CURRENT DRUG METABOLISM
- The effects of obesity on drug pharmacokinetics in humans
- (2011) Glynn A Morrish et al. Expert Opinion on Drug Metabolism & Toxicology
- Pediatric Underdosing of Efavirenz
- (2011) Quirine Fillekes et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Ageing with HIV: medication use and risk for potential drug-drug interactions
- (2011) C. Marzolini et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Integration of population pharmacokinetics and pharmacogenetics: an aid to optimal nevirapine dose selection in HIV-infected individuals
- (2011) A. Schipani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens
- (2011) C. Wyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Genetic Variants of ABCC10, a Novel Tenofovir Transporter, Are Associated With Kidney Tubular Dysfunction
- (2011) Sudeep P. Pushpakom et al. JOURNAL OF INFECTIOUS DISEASES
- Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS
- (2011) Neill J. Liptrott et al. Pharmacogenetics and Genomics
- Cytochrome P450-specific human PBPK/PD models for the organophosphorus pesticides: Chlorpyrifos and parathion
- (2011) Robert J. Foxenberg et al. TOXICOLOGY
- Identification of human UGT isoforms responsible for glucuronidation of efavirenz and its three hydroxy metabolites
- (2011) S. K. Bae et al. XENOBIOTICA
- Age-Related Changes in Plasma Concentrations of the HIV Protease Inhibitor Lopinavir
- (2010) Keith W. Crawford et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Pharmacokinetics and Disposition of Rilpivirine (TMC278) Nanosuspension as a Long-Acting Injectable Antiretroviral Formulation
- (2010) G. van 't Klooster et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Population Pharmacokinetic Modeling of the Association between 63396C->T Pregnane X Receptor Polymorphism and Unboosted Atazanavir Clearance
- (2010) A. Schipani et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effect of Antacids on the Pharmacokinetics of Raltegravir in Human Immunodeficiency Virus-Seronegative Volunteers
- (2010) J. J. Kiser et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Prevalence of comedications and effect of potential drug–drug interactions in the Swiss HIV Cohort Study
- (2010) Catia Marzolini et al. ANTIVIRAL THERAPY
- Effect of Obesity on the Pharmacokinetics of Drugs in Humans
- (2010) Michael J. Hanley et al. CLINICAL PHARMACOKINETICS
- Efavirenz Primary and Secondary Metabolism In Vitro and In Vivo: Identification of Novel Metabolic Pathways and Cytochrome P450 2A6 as the Principal Catalyst of Efavirenz 7-Hydroxylation
- (2010) E. T. Ogburn et al. DRUG METABOLISM AND DISPOSITION
- Antiretroviral Treatment of Adult HIV Infection
- (2010) Melanie A. Thompson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens
- (2010) D. Gonzalez de Requena et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Effects of concurrent administration of nevirapine on the disposition of quinine in healthy volunteers
- (2010) Julius O. Soyinka et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Cytochrome P450-mediated metabolism in the human gut wall
- (2010) Kirstin Thelen et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- HIV protease inhibitors are substrates for OATP1A2, OATP1B1 and OATP1B3 and lopinavir plasma concentrations are influenced by SLCO1B1 polymorphisms
- (2010) Ruben C. Hartkoorn et al. Pharmacogenetics and Genomics
- Influence of host genetic factors on efavirenz plasma and intracellular pharmacokinetics in HIV-1-infected patients
- (2010) Laure Elens et al. PHARMACOGENOMICS
- Increasing Rates of Obesity among HIV-Infected Persons during the HIV Epidemic
- (2010) Nancy Crum-Cianflone et al. PLoS One
- Population-Based Mechanistic Prediction of Oral Drug Absorption
- (2009) Masoud Jamei et al. AAPS Journal
- Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance
- (2009) Christina M Marra et al. AIDS
- CYP2B6, CYP2A6 and UGT2B7 genetic polymorphisms are predictors of efavirenz mid-dose concentration in HIV-infected patients
- (2009) Awewura Kwara et al. AIDS
- Pharmacokinetic interactions between ritonavir and quinine in healthy volunteers following concurrent administration
- (2009) Julius O. Soyinka et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Effects of Omeprazole on Plasma Levels of Raltegravir
- (2009) Marian Iwamoto et al. CLINICAL INFECTIOUS DISEASES
- Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action
- (2009) Caroline Bazzoli et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics and drug metabolism in the elderly
- (2009) Ulrich Klotz DRUG METABOLISM REVIEWS
- The relation between treatment outcome and efavirenz, atazanavir or lopinavir exposure in the NORTHIV trial of treatment-naïve HIV-1 infected patients
- (2009) Filip Josephson et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Alteration of pharmacokinetics of proguanil in healthy volunteers following concurrent administration of efavirenz
- (2009) Julius Olugbenga Soyinka et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- The Simcyp®Population-based ADME Simulator
- (2009) Masoud Jamei et al. Expert Opinion on Drug Metabolism & Toxicology
- Efavirenz in the therapy of HIV infection
- (2009) Natella Y Rakhmanina et al. Expert Opinion on Drug Metabolism & Toxicology
- Cytochrome P450 2B6 516G→T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population
- (2009) TW Mahungu et al. HIV MEDICINE
- The impact of pharmacogenetics on HIV therapy
- (2009) T W Mahungu et al. INTERNATIONAL JOURNAL OF STD & AIDS
- Changes in Cognition During Antiretroviral Therapy: Comparison of 2 Different Ranking Systems to Measure Antiretroviral Drug Efficacy on HIV-Associated Neurocognitive Disorders
- (2009) Valerio Tozzi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Database for Physiologically Based Pharmacokinetic (PBPK) Modeling: Physiological Data for Healthy and Health-Impaired Elderly
- (2009) Chad M. Thompson et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS
- Pharmacokinetic Assessment of Multiple ATP-binding Cassette Transporters: The Power of Combination Knockout Mice
- (2009) J. S. Lagas et al. MOLECULAR INTERVENTIONS
- Renal Failure in Cirrhosis
- (2009) Pere Ginès et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetics of tenofovir treatment
- (2009) Sonia Rodriguez-Novoa et al. PHARMACOGENOMICS
- Validation of the CNS Penetration-Effectiveness Rank for Quantifying Antiretroviral Penetration Into the Central Nervous System
- (2008) Scott Letendre ARCHIVES OF NEUROLOGY
- A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers
- (2008) Monika Schöller-Gyüre et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Cultured CD4T cells and primary human lymphocytes express hOATPs: intracellular accumulation of saquinavir and lopinavir
- (2008) O Janneh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Physiology-Based Simulations of a Pathological Condition
- (2008) Andrea N Edginton et al. CLINICAL PHARMACOKINETICS
- Free Drug Metabolic Clearance in Elderly People
- (2008) Jennifer M Butler et al. CLINICAL PHARMACOKINETICS
- Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Lineshape Analysis
- (2008) Sheila Annie Peters CLINICAL PHARMACOKINETICS
- Expression of UGT1A and UGT2B mRNA in Human Normal Tissues and Various Cell Lines
- (2008) A. Nakamura et al. DRUG METABOLISM AND DISPOSITION
- Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction
- (2008) Roger K. Verbeeck EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Pharmacokinetic–pharmacodynamic relationship of NRTIs and its connection to viral escape: An example based on zidovudine
- (2008) Max von Kleist et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults
- (2008) N Clumeck et al. HIV MEDICINE
- The gastrointestinal microbiota as a site for the biotransformation of drugs
- (2008) Tiago Sousa et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients
- (2008) C. Wyen et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Pharmacologic Consideration for the Use of Antiretroviral Agents in the Elderly
- (2008) Martin S. Rhee et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Blood–brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration
- (2008) Anna L. Bartels et al. NEUROBIOLOGY OF AGING
- Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use ofin silicophysiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man
- (2008) G. Allan et al. XENOBIOTICA
- The problems in scaling adult drug doses to children
- (2007) T N Johnson ARCHIVES OF DISEASE IN CHILDHOOD
- Significant Decrease in Nelfinavir Systemic Exposure After Omeprazole Coadministration in Healthy Subjects
- (2007) Annie F Fang et al. PHARMACOTHERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started